A protocolized approach to endoscopic hydrostatic versus pneumatic balloon dilation therapy for gastric sleeve stenosis: a multicenter study and meta-analysis.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 20 01 2020
revised: 30 04 2020
accepted: 06 05 2020
pubmed: 10 7 2020
medline: 28 4 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Gastric sleeve stenosis (GSS) is reported in .7% to 4% of cases after sleeve gastrectomy. Two endoscopic balloon dilation techniques are available with no clear consensus on the therapeutic approach. To compare the treatment efficacy and safety between hydrostatic and pneumatic balloon dilations for GSS. Academic referral centers, United States and a meta-analysis. Consecutive patients who presented with GSS and underwent endoscopic hydrostatic and/or pneumatic balloon dilations at 3 tertiary care hospitals were included. Clinical success was defined as an improvement of symptoms that allowed the patient to avoid further interventions. A systematic literature search was performed to identify relevant studies for meta-analysis. Of 46 patients, 13 had pneumatic dilation only, 26 had hydrostatic dilation only, and 7 had pneumatic dilation after failed hydrostatic dilation. Clinical success was not significantly different among the 3 groups with the success rates of 30.8%, 57.6%, and 57.1% (P = .25) after single dilation and 61.5%, 63.6%, and 71.4% (P = .90) after serial dilations in the pneumatic group, hydrostatic group, and pneumatic after failed hydrostatic group, respectively. Patients who failed hydrostatic balloon dilation (n = 7) had a success rate of 71.4% with subsequent pneumatic dilation. Two serious adverse events were observed in the pneumatic group, whereas none were observed in the hydrostatic group. A meta-analysis of 16 studies involving 360 patients demonstrated higher clinical success with single pneumatic balloon dilation compared with hydrostatic balloon dilation (62.2% versus 36.4%; P = .007) with higher adverse events (3 versus 0 events). Hydrostatic balloon dilation should be considered as an initial modality for GSS given its acceptable success rate and high safety profile. In those who fail hydrostatic balloon dilation, a subsequent step-up approach to pneumatic balloon dilation or revisional surgery should be attempted.

Sections du résumé

BACKGROUND BACKGROUND
Gastric sleeve stenosis (GSS) is reported in .7% to 4% of cases after sleeve gastrectomy. Two endoscopic balloon dilation techniques are available with no clear consensus on the therapeutic approach.
OBJECTIVES OBJECTIVE
To compare the treatment efficacy and safety between hydrostatic and pneumatic balloon dilations for GSS.
SETTING METHODS
Academic referral centers, United States and a meta-analysis.
METHODS METHODS
Consecutive patients who presented with GSS and underwent endoscopic hydrostatic and/or pneumatic balloon dilations at 3 tertiary care hospitals were included. Clinical success was defined as an improvement of symptoms that allowed the patient to avoid further interventions. A systematic literature search was performed to identify relevant studies for meta-analysis.
RESULTS RESULTS
Of 46 patients, 13 had pneumatic dilation only, 26 had hydrostatic dilation only, and 7 had pneumatic dilation after failed hydrostatic dilation. Clinical success was not significantly different among the 3 groups with the success rates of 30.8%, 57.6%, and 57.1% (P = .25) after single dilation and 61.5%, 63.6%, and 71.4% (P = .90) after serial dilations in the pneumatic group, hydrostatic group, and pneumatic after failed hydrostatic group, respectively. Patients who failed hydrostatic balloon dilation (n = 7) had a success rate of 71.4% with subsequent pneumatic dilation. Two serious adverse events were observed in the pneumatic group, whereas none were observed in the hydrostatic group. A meta-analysis of 16 studies involving 360 patients demonstrated higher clinical success with single pneumatic balloon dilation compared with hydrostatic balloon dilation (62.2% versus 36.4%; P = .007) with higher adverse events (3 versus 0 events).
CONCLUSIONS CONCLUSIONS
Hydrostatic balloon dilation should be considered as an initial modality for GSS given its acceptable success rate and high safety profile. In those who fail hydrostatic balloon dilation, a subsequent step-up approach to pneumatic balloon dilation or revisional surgery should be attempted.

Identifiants

pubmed: 32641283
pii: S1550-7289(20)30267-7
doi: 10.1016/j.soard.2020.05.009
pii:
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1543-1553

Informations de copyright

Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Veeravich Jaruvongvanich (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Reem Matar (R)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Azizullah Beran (A)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Daniel B Maselli (DB)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Andrew C Storm (AC)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Victoria Gómez (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida.

Eric J Vargas (EJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Todd A Kellogg (TA)

Division of Surgery, Mayo Clinic, Rochester, Minnesota.

Travis J McKenzie (TJ)

Division of Surgery, Mayo Clinic, Rochester, Minnesota.

Rahul Pannala (R)

Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona.

Manoel Galvao Neto (M)

ABC Medical School, Sao Paulo, Brazil.

Andre Texeira (A)

Orlando Regional Medical Center, Orlando Health, Orlando, Florida.

Barham K Abu Dayyeh (BK)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: AbuDayyeh.Barham@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH